Nasus Pharma Ltd. (NSRX) at a glance

Nasus Pharma Ltd. (NSRX) is a micro-cap Healthcare company. It trades at $3.36, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 42/100 overall. Its strongest dimension is Growth (50/100) and its weakest is Momentum (25/100).

Price
$3.36
Market cap
$33.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.98 to $9.99
Vestovix Score42/ 100How this works
Value
40
Growth
50
Income
40
Safety
46
Momentum
25

Other Healthcare stocks

See all